Search

everythinglearnresearchcommunity

for

Search:↓

New methods reliably assess hair regrowth and scalp health in hair loss patients.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Low-level light therapy safely increases hair growth in various types of hair loss.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

Finasteride and low-level laser therapy are similarly effective for frontal pattern hair loss.

Higher sebum levels are linked to more severe male baldness.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Nano-cerium oxide may help treat hair loss by improving hair growth and reducing certain skin proteins.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Most people in the surveyed area experience hair loss, but they are not aware of the role of diet, iron, hormones, genetics, and possibly water quality in causing it.

No link found between hair loss severity and PSA levels in men.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Lower DHT levels lead to more body hair growth.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

Finasteride effectively treats baldness but may cause sexual side effects.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.